Top Markets
#1 bitcastle Token bitcastle Token +150.75%
#2 MowCat MowCat +86.64%
#3 MarsCoin MarsCoin +56.26%
#4 Palladium Network Palladium Network +53.08%
#5 Siren Siren +29.58%
#6 Bedrock Bedrock +25.17%
#7 Useless Coin Useless Coin +24.14%
#8 Pons Pons +19.31%
#9 ICON ICON +18.24%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
Coin of the day
bitcastle Token bitcastle Token
Setări
Limbă
ROMâNă
Monedă
USD
Temă
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang în acțiuni #16760
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Preț acțiune
$3.78
Ultima sincronizare: 2026-03-17
Capitalizare de piață
$276.54M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
44.44%
Țară
CA
Tranzacționează NervGen Pharma Corp. (NGEN)

Categorie

Healthcare
Venituri pentru NervGen Pharma Corp. (NGEN)
Venituri în Sep 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale NervGen Pharma Corp., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru NervGen Pharma Corp. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH